Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02862691 · ClinicalTrials.gov registry record · Phase 2
Percocet vs. Bupivicaine for Toothaches in the ED
A Phase 2 study, sponsored by Stony Brook University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT02862691: Clinical Trial Phase 2 study, sponsored by Stony Brook University.
NCT02862691 is a Phase 2 study that was terminated before completion, run by Stony Brook University. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02862691, a Phase 2 study, was terminated before completion, sponsored by Stony Brook University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The goal of this study is to compare the speed and adequacy of pain relief in Emergency Department patients with a toothache after an oral analgesic or a local anesthetic administered as a nerve block or by local infiltration.
Primary Outcome
Patients whose pain is reduced from severe (7-10) to mild (0-3) will be considered as having a meaningful reduction in pain.
Interventions
- DRUG Acetaminophen/Oxycodone (Oral analgesic)
- DRUG Bupivicaine (Injectable local anesthetic)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-08-01 |
| Est. Completion | 2017-08-01 |
| Phase | Phase 2 |
Why NCT02862691 stopped before completion
NCT02862691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen/Oxycodone (Oral analgesic) is the first listed.
NCT02862691 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02862691 about?
NCT02862691 is a clinical study titled "Percocet vs. Bupivicaine for Toothaches in the ED". The goal of this study is to compare the speed and adequacy of pain relief in Emergency Department patients with a toothache after an oral analgesic or a local anesthetic administered as a nerve block or by local infiltration.
What is the current status of trial NCT02862691?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2016-08-01. Estimated completion is 2017-08-01.
What interventions are being tested in trial NCT02862691?
The interventions under investigation include: Acetaminophen/Oxycodone (Oral analgesic) (DRUG), Bupivicaine (Injectable local anesthetic) (DRUG).
Who is sponsoring clinical trial NCT02862691?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02862691's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI